Why India’s Diagnostic Chains Are Losing Pricing Power
An employee packages polymerase chain reaction reagent kits at a manufacturing facility. Photographer: Jasper Juinen/Bloomberg

Why India’s Diagnostic Chains Are Losing Pricing Power

Even as Metropolis Healthcare Ltd. launched its initial public offering earlier this month, revenue growth of listed diagnostic companies is slowing amid stiff competition from their unorganised pe...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.